HIV drug used to reverse effects of virus that causes cervical cancer — ScienceDaily
source : http://www.sciencedaily.com/releases/2014/02/140217085248.htm
source : http://www.sciencedaily.com/releases/2014/02/140217085248.htm
The study, published online by the journal AIDS, was authored by Jennifer Smith, PhD, MPH, research associate professor with the Gillings School of Global Public Health and member of the UNC Lineberger Comprehensive Cancer Center, and Anne Rositch, PHD, MSPH, assistant professor with the University of Maryland School of Medicine. "These data from Kenya add to a mounting evidence showing a higher risk of HIV acquisition among individuals with genital HPV infections," said Smith. Men in the study with at least one occurrence of HPV infection faced double the risk of acquiring HIV, and those with three or more HPV infections had more than three times the risk of developing HIV. This pattern was consistent in both circumcised and uncircumcised men…
Results from the research, which looked retrospectively at the treatment of women diagnosed with cervical cancer during a two year period, showed 18% of cervical cancer patients in the East African country died within two years of a diagnosis. Dr Ian Hampson, from The University of Manchester’s Institute of Cancer Sciences who oversaw the research, said the findings, published in PLOS One this week, add further weight to the call to spend more on cancer screening and prevention in Kenya…